NCT04081740 (CADRhé) is a clinical trial in Asthma, sponsored by University Hospital, Montpellier.

Who is sponsoring NCT04081740?

NCT04081740 is sponsored by University Hospital, Montpellier.

What condition does NCT04081740 study?

NCT04081740 studies Asthma, COPD, Bronchiectasis.

Is NCT04081740 still recruiting?

NCT04081740 is currently completed. Last updated 7 November 2019.

Last reviewed 2019-11-07 · How we verify

NCT04081740: CADRhé

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biological Determinants of Sputum Rheology in Chronic Airway Diseases

Completed Last updated 7 November 2019

What this trial tests

trial in Asthma in 48 participants. Completed in 15 October 2019.

Timeline

15 September 2019

Primary endpoint
15 October 2019

15 October 2019

Quick facts

Lead sponsor	University Hospital, Montpellier
Status	Completed
Study type	OBSERVATIONAL
Enrollment	48
Start date	15 September 2019
Primary completion	15 October 2019
Estimated completion	15 October 2019
Sites	1 location across France

Conditions studied

Asthma — all drugs for Asthma →
COPD — all drugs for COPD →
Bronchiectasis — all drugs for Bronchiectasis →

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Asthma or COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to investigate the biological determinants of sputum rheology variations.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Rheology predicts sputum eosinophilia in patients with muco-obstructive lung diseases.
Volpato M, Vialaret J, Hirtz C, Petit A, et al · · 2022 · cited 15× · PMID 35843096 · DOI 10.1016/j.bbrc.2022.07.025
Methods of Sputum and Mucus Assessment for Muco-Obstructive Lung Diseases in 2022: Time to "Unplug" from Our Daily Routine!
Charriot J, Volpato M, Petit A, Vachier I, et al · · 2022 · cited 10× · PMID 35269434 · DOI 10.3390/cells11050812

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04081740 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 7 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04081740.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing